Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

RABORAL VRG RACCOON BAITS, COATED SACHETS

Active
1171341Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The U.S. Department of Agriculture’s Wildlife Services is seeking to procure up to 6,965,000 units of RABORAL V-RG oral rabies vaccine baits for use during 2026 and 2027, with the sole purpose of controlling rabies in wildlife populations. Only two bait types are authorized for use in the United States: the coated sachet and the fishmeal polymer, both manufactured by Boehringer-Ingelheim Animal Health USA and containing the same live recombinant vaccine that uses an attenuated Vaccinia virus to deliver the rabies glycoprotein gene. The vaccine is incapable of causing rabies but effectively stimulates antibody production in target carnivore species when administered in proper dosage. Each bait is labeled with clear identification and a toll-free information number to assist the public. To ensure readiness for urgent outbreaks, the contract includes provisions for the government to purchase and store a limited supplemental supply beyond standard operational needs. The contract is a firm fixed price IDIQ with a one-year term, allowing for on-demand ordering during the period. All shipments must be delivered FOB destination to specified locations within the contiguous United States, with exact addresses coordinated post-award. The solicitation number is 1171341, with bids due by September 7, 2026, and submissions must be sent exclusively to todd.k.bierl@usda.gov. Late responses will not be accepted, and all proposals are limited to no more than 100 pages. The contracting office is part of APHIS’s Emergency Acquisition Marketing and Regulatory Program Business under the Animal and Plant Health Inspection Service, with Todd K. Bierl serving as the primary point of contact for all inquiries and submissions.

General Info

USDA to procure up to 6.97 million rabies vaccine baits for 2026–2027 wildlife use.

Agency

Department Of Agriculture → Aphis-WsView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

Concord, NH, 03301, USA

Set-Aside

NONE

Documents

(1)

Solicitation 1263952600262 for RABORAL V-RG Oral Rabies Vaccine

PDFrfq

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseCombined Synopsis
Posted

Combined Synopsis

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Agriculture → Aphis-Ws
Contacts1 person available
OfficeMoses Lake, WA, 98837, USA
Organization / Agency
Department Of Agriculture → Aphis-Ws
View Agency Profile
Office AddressMoses Lake, WA, 98837, USA

Full Description

Show more

This acquisition is for RABORAL V-RG® containing oral rabies vaccine (ORV) on demand during 2026 and 2027.  Wildlife Services proposes purchasing up to 6,965,000 units of the RABORAL V-RG® bait.  Two bait constructs containing the oral rabies vaccine are available – the coated sachet and fishmeal polymer. Each bait contains an identifying label as to the contents of the bait and a toll-free phone number where people can obtain information about the baits. The oral vaccine contained in all bait types is the same, live recombinant that uses attenuated Vaccinia (V) virus to vector the rabies glycoprotein (RG) gene. The vaccine CANNOT cause rabies but produces antibodies against rabies infection in most carnivore species that receive an adequate dose.


Rabies control frequently requires immediate access to additional baits in excess of supply ordered and delivered for standard operations.  To meet this critical need, WS has a requirement to purchase in advance and store a limited supply of baits.  The only ORV baits fully licensed for use in the United States by USDA or other appropriate federal, state or county agencies are the coated sachet (128370), and fishmeal polymer (128425), both of which are manufactured under the product name RABORAL V-RG®  by Boehringer-Ingelheim Animal Health USA, Inc. (formerly Merial, Inc.), Athens, Georgia. 



Contract Type and Term


The government is awarding a firm fixed price IDIQ contract with a one-year period of performance.



Delivery


Purchase price will include all shipping costs, FOB destination, to the CONUS locations specified at time of order. Specific shipping addresses will be coordinated with the technical POC after award.



Read SOW!!


No more than 100 pages.


No late submissions accepted.


Submissions/Quotes submitted to: todd.k.bierl@usda.gov


Todd K. Bierl (Major Program Contracting Officer) Emergency Acquisition Marketing and Regulatory Program Business (MRPBS) Acquisition and Asset Management Division (AAMD) Acquisition Branch Animal and Plant Health Inspection Service (APHIS) Office#(612)336-3465 Cell# (612)500-1321/(763)286-8084



Similar Contracts

Same NAICS industry code

NAICS: 325412
New
Federal
SUPPLY AND DELIVERY OF MEDICAL SUPPLIES
Solicitation # 19RP3826Q0059
The U.S. Department of State through the U.S. Embassy Manila is soliciting quotations for the supply and delivery of medical supplies under solicitation number 19RP3826Q0059, with a NAICS code of 325412. Offerors must submit their proposals electronically by August 10, 2026, at 4:00 p.m. Philippine local time, using MS-Word 2007/2010, MS-Excel 2007/2010, or Adobe Acrobat PDF formats, with individual files not exceeding 10MB; larger submissions must be split into multiple emails each under the size limit. Proposals must be in English and include the completed SF-1449 form, Section I Pricing, Section 5 Representations and Certifications, and any additional requirements outlined in Section 3 of the solicitation. All offerors must be registered in the System for Award Management (SAM) prior to submission, as mandated by FAR 4.1102, and failure to register will result in non-responsibility determination. Questions regarding the solicitation must be submitted in writing to ManilaContracting@state.gov no later than July 17, 2026, at 4:00 p.m. Philippine local time. The government intends to award a contract to the responsible vendor submitting the lowest priced acceptable offer, potentially holding discussions only if necessary. No details on delivery schedules, inspection criteria, packaging specifications, or evaluation factors are provided in the available documentation.
US Embassy Manila

POSTED

about 23 hours ago

DEADLINE

in 17 days
View Details
NAICS: 325412
New
Federal
Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
Solicitation # HT9402-26-Q-9402
The Department of War, through the Defense Health Agency, is soliciting quotes under RFQ HT9402-26-Q-9402 to support the establishment and maintenance of the Uniform Formulary for the Military Health System, as mandated by 10 U.S.C. § 1074g and 32 CFR § 199.21. The process involves evaluating pharmaceutical agents for clinical and cost effectiveness to determine placement on the Uniform Formulary as generic, formulary, Basic Core Formulary, Extended Core Formulary, or non-formulary, with the goal of optimizing pharmaceutical procurement through Uniform Formulary Blanket Purchase Agreements and Uniform Formulary Additional Discount Program Agreements. Four newly approved drugs—Awiqli Flextouch (basal insulin), Cavhanza (BCR-ABL tyrosine kinase inhibitor for leukemia and lymphoma), Lipfendra (PCSK9 antilipidemic), and Trutakna (nephrology agent)—are scheduled for review at the November 2026 Pharmacy and Therapeutics Committee meeting, and industry responses will inform their inclusion or exclusion. Responses to the RFQ are due by August 27, 2026, with a pre-quotation teleconference scheduled for August 12, 2026, to clarify requirements. Clinical data submissions for evaluation must be sent via email to the designated point of contact by the deadline specified in Part 2.3.2. The solicitation, issued by the Defense Health Agency under NAICS code 325412, is managed from Aurora, Colorado, with performance centered in San Antonio, Texas. Primary contact is Julia Trang, with Stephanie Erpelding as secondary contact, and all submissions and inquiries must adhere to the instructions outlined in RFQ HT9402-26-Q-9402 to be considered valid.
Defense Health Agency

POSTED

about 23 hours ago

DEADLINE

in 20 days
View Details
NAICS: 325412
New
Federal
Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
Solicitation # HT9402-26-Q-9401
The Department of War, through the Defense Health Agency, is soliciting quotations to support the establishment and maintenance of the Uniform Formulary for the Military Health System, as mandated by federal law and regulation. The process involves evaluating pharmaceutical agents for clinical and cost effectiveness to determine their placement on the formulary tiers—generic, formulary, Basic Core Formulary, Extended Core Formulary, or non-formulary—with the goal of optimizing patient access and managing expenditures. The solicitation includes the potential award of Uniform Formulary Blanket Purchase Agreements and Uniform Formulary Additional Discount Program Agreements contingent upon the Pharmacy and Therapeutics Committee’s recommendations. Two drug classes are under review for the November 2026 meeting: Atopy—Topical Agents including Anzupgo, Eucrisa, Opzelura, Vtama, and Zoryve; and Lung Cancer—METEX14, including Tabrecta and Tepmetko. The request for quotation, identified as HT9402-26-Q-9401, outlines detailed procedures, appendices for BPA and ADP, and key submission deadlines. Responses are required by October 1, 2026, with a mandatory pre-quotation teleconference scheduled for August 12, 2026. The solicitation is issued by the Defense Health Agency under the Department of Defense, with the primary point of contact located in Aurora, Colorado, and performance expected in Texas. Vendors must adhere strictly to the instructions provided in the RFQ to ensure eligibility for consideration under the uniform formulary program, which directly impacts pharmacy benefits for military personnel and their dependents.
Defense Health Agency

POSTED

about 23 hours ago

DEADLINE

in about 2 months
View Details
NAICS: 325412
New
DIBBS
Veterinary Pharmaceutical Tablet SupplierThe contract requires the manufacture and supply of Maropitant Citrate 160mg veterinary tablets packaged in blister packs containing four tablets per sheet, fully compliant with FDA and Defense Logistics Agency specifications. The product must meet all regulatory and quality standards for veterinary use, with strict adherence to packaging, labeling, and stability requirements to ensure efficacy and safety during storage and transport. The supplier is expected to deliver consistent, high-quality output in accordance with pharmaceutical manufacturing best practices, and all materials must be traceable and documented to support federal procurement compliance. This subcontract is issued under the Medical Supply Chain Pharm FSA, a division of the Department of Defense, with performance required at the APO ZIP code 09227-0000. The solicitation was posted on August 5, 2026, and responses are due by August 11, 2026, indicating a tight turnaround for proposals. The NAICS code 325412 identifies this as a pharmaceutical and biological product manufacturing contract, emphasizing the technical and regulatory expertise necessary for participation. While no set-aside details are provided, the contract is open to qualified subcontractors capable of meeting DoD’s stringent pharmaceutical supply chain requirements, with all deliverables aligned to ensure uninterrupted availability of critical veterinary medications for military and associated personnel.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

2 days ago

DEADLINE

in 4 days
View Details